The ReadoutWe can’t stop podcasting & cytokines are back By Adam Feuerstein March 30, 2018 Reprints Alex Hogan/STAT The Readout for March 30, 2018 About the Author Reprints Adam Feuerstein Senior Writer, Biotech Adam Feuerstein is STAT’s national biotech columnist, reporting on the intersection of biotech and Wall Street. He's also a co-host of "The Readout LOUD" podcast. [email protected] @adamfeuerstein
The Readout Meghana Keshavan Regeneron targets obesity, a new microbiome deal, & comparing cancer drug costs
The Readout Damian Garde Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries & regenerating heart tissue
Insurance John Wilkerson STAT Plus: Key senators blast Medicare Advantage insurers for ‘exorbitant salaries,’ ‘massive payouts’ to execs
Health Tech Mohana Ravindranath and Casey Ross STAT Plus: Cerebral and other telehealth startups face new legal and regulatory challenges over ad models
A STAT Investigation Casey Ross and Bob Herman STAT Plus: Denied by AI: How Medicare Advantage plans use algorithms to cut off care for seniors in need
